RESMED INC (RMD)
Surgical & Medical Instruments & Apparatus
Latest Price
$210.98
TTM P/E
20.35
Normalized P/E
28.14
Div Yield
1.10%
Book Value
44.67
P/B Ratio
4.72
Valuation metrics
adjust assumptions →EPS: $9.51
Book value / share: $40.77
Formula: √(22.5 × EPS × BVPS)
Graham Number
$93.40
56% downside
Norm. op. income: $1.0B (median of 7yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$59.15
72% downside
Base FCF: $634M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$326.03
+55% upside
EPS: $9.51
Target P/E: 28×
Formula: EPS × P/E
P/E Fair Value
$266.28
+26% upside
Institutional Ownership
65.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.09M | $2.71B | 8.34% | -254.6K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.47M | $2.13B | 6.53% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.86M | $1.76B | 5.42% | -- | 2026-03-31 |
| STATE STREET CORP | 6.64M | $1.49B | 4.58% | +17.8K | 2026-03-31 |
| Bank of New York Mellon Corp | 4.93M | $1.10B | 3.40% | +34.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.35M | $973.0M | 3.00% | +50.0K | 2026-03-31 |
| MORGAN STANLEY | 2.69M | $603.0M | 1.85% | -204.9K | 2026-03-31 |
| Invesco Ltd. | 1.96M | $439.0M | 1.35% | +4.7K | 2026-03-31 |
| NORTHERN TRUST CORP | 1.73M | $387.0M | 1.19% | -59.7K | 2026-03-31 |
| FIRST TRUST ADVISORS LP | 1.54M | $345.0M | 1.06% | +20.2K | 2026-03-31 |